A Phase IIa randomized double-blind placebo controlled study to evaluate the safety and feasibility of oral triheptanoin as an add-on treatment to adolescent and adult patients with medically refractory epilepsy
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2017
At a glance
- Drugs Triheptanoin (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Acronyms TRIP-E
- 08 Jun 2016 Status changed from recruiting to completed.
- 15 Aug 2012 Actual initiation date (Apr 2012) added as reported by Australian New Zealand Clinical Trials Registry.
- 06 Mar 2012 New trial record